Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000541570 | SCV000641635 | benign | Tuberous sclerosis 1 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000565824 | SCV000675379 | likely benign | Hereditary cancer-predisposing syndrome | 2022-12-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001675599 | SCV001895645 | benign | not provided | 2021-02-25 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 18830229, 32906206, 21309039) |
Genome- |
RCV000541570 | SCV002040001 | likely benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000042271 | SCV004840445 | benign | Tuberous sclerosis syndrome | 2023-07-22 | criteria provided, single submitter | clinical testing | |
Tuberous sclerosis database |
RCV000042271 | SCV000066060 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation | ||
Clinical Genetics, |
RCV001675599 | SCV001918703 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001675599 | SCV001951446 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001675599 | SCV001964544 | uncertain significance | not provided | no assertion criteria provided | clinical testing |